Epinephrine and the genesis of hypertension.
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Several lines of evidence suggest a psychophysiological link between stress, adrenomedullary activation, and the genesis of hypertension. Experimental data support four important concepts: 1) epinephrine stimulates prejunctional beta 2-adrenergic receptors that facilitate norepinephrine release from sympathetic nerve endings; 2) epinephrine can be converted into a cotransmitter by neuronal uptake and on subsequent release augment the simultaneous discharge of norepinephrine; 3) exogenous epinephrine can induce sustained hypertension in rats; and 4) there is a period of critical sensitivity to endogenous epinephrine in a genetic model of rat hypertension. Plasma epinephrine concentrations are elevated in many young subjects with borderline or mild hypertension. The hypothesis that intermittent surges in epinephrine could initiate or promote the development of primary hypertension by amplifying peripheral neurotransmission, both directly (facilitative effect) and indirectly (cotransmitter action), is supported by reports that hemodynamic and noradrenergic responses to sympathetic activation can be augmented by increases in endogenous epinephrine or by its local or systemic (up to 30 ng/kg/min) infusion. Such responses have been documented in both normotensive and hypertensive subjects and can be blocked by propranolol. Although the weight of evidence (mostly indirect) indicates that epinephrine can augment norepinephrine release in humans, the epinephrine hypothesis, itself, remains unproven. Expression of hypertension by this mechanism may be restricted to a specific epinephrine-sensitive subset of individuals with a genetic predisposition to high blood pressure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Physiological aspects of primary hypertension.
Folkow, B. (1982) · Physiological Reviews · doi:10.1152/physrev.1982.62.2.347 · Cited by 1,768
Cryer, P. E., Haymond, M. W., Santiago, J. V., & Shah, S. D. (1976) · New England Journal of Medicine · doi:10.1056/nejm197609092951101 · Cited by 1,101
Hypokalemia from Beta 2 -Receptor Stimulation by Circulating Epinephrine
Brown, M. J., Brown, D. C., & Murphy, M. B. (1983) · New England Journal of Medicine · doi:10.1056/nejm198312083092303 · Cited by 644
Esler, M., Jennings, G., Korner, P., Willett, I., Dudley, F., Hasking, G., Anderson, W., & Lambert, G. (1988) · Hypertension · doi:10.1161/01.hyp.11.1.3 · Cited by 642
Anderson, E. A., Sinkey, C. A., Lawton, W. J., & Mark, A. L. (1989) · Hypertension · doi:10.1161/01.hyp.14.2.177 · Cited by 632
Clutter, W. E., Bier, D. M., Shah, S. D., & Cryer, P. E. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109840 · Cited by 576
ADLER‐GRASCHINSKY, E., & LANGER, S. Z. (1975) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1975.tb07328.x · Cited by 335
Folkow, B., Di Bona, G. F., Hjemdahl, P., Torén, P. H., & Wallin, B. G. (1983) · Hypertension · doi:10.1161/01.hyp.5.4.399 · Cited by 218
Cited by
Vascular Adrenoceptors: An Update
Guimarães, S., & Moura, D. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01495-9 · Cited by 700
Prognostic Significance of Small-Artery Structure in Hypertension
Rizzoni, D., Porteri, E., Boari, G. E. M., De Ciuceis, C., Sleiman, I., Muiesan, M. L., Castellano, M., Miclini, M., & Agabiti-Rosei, E. (2003) · Circulation · doi:10.1161/01.cir.0000095031.51492.c5 · Cited by 496
Spironolactone Improves Angiotensin-Induced Vascular Changes and Oxidative Stress
Virdis, A., Neves, M. F., Amiri, F., Viel, E., Touyz, R. M., & Schiffrin, E. L. (2002) · Hypertension · doi:10.1161/01.hyp.0000034738.79310.06 · Cited by 399
Olusi, S. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0802066 · Cited by 390
Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure
Floras, J. S. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90466-e · Cited by 361
Self-citationDe Ciuceis, C., Amiri, F., Brassard, P., Endemann, D. H., Touyz, R. M., & Schiffrin, E. L. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000181743.28028.57 · Cited by 350
Lower body negative pressure as a model to study progression to acute hemorrhagic shock in humans
Cooke, W. H., Ryan, K. L., & Convertino, V. A. (2004) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01155.2003 · Cited by 346
Mechanisms of Abnormal Renal Sodium Handling in Obesity Hypertension
Hall, J. (1997) · American Journal of Hypertension · doi:10.1016/s0895-7061(97)00075-7 · Cited by 213
Walton, K. G., Pugh, N. D. C., Gelderloos, P., & Macrae, P. (1995) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.1995.1.263 · Cited by 163
Plasma catecholamines—analytical challenges and physiological limitations
Hjemdahl, P. (1993) · Baillière's Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80179-x · Cited by 143
Eisenhofer, G., Friberg, P., Pacak, K., Goldstein, D. S., Murphy, D. L., Tsigos, C., Quyyumi, A. A., Brunner, H. G., & Lenders, J. W. M. (1995) · Clinical Science · doi:10.1042/cs0880533 · Cited by 123
“Neverthe less, the findings of higher plasma concentrations of adrenaline in hypertensive than in normotensive subjects and in males than in females, while consis tent with other studies [26, 27], are further sup ported and strengthened by similar differences in plasma concentrations of free or sulphateconjugated m…”
Phenotypic Evidence of Faulty Neuronal Norepinephrine Reuptake in Essential Hypertension
Rumantir, M. S., Kaye, D. M., Jennings, G. L., Vaz, M., Hastings, J. A., & Esler, M. D. (2000) · Hypertension · doi:10.1161/01.hyp.36.5.824 · Cited by 95
Rumantir, M. S., Jennings, G. L., Lambert, G. W., Kaye, D. M., Seals, D. R., & Esler, M. D. (2000) · Journal of Hypertension · doi:10.1097/00004872-200018060-00009 · Cited by 72
Metadata
- Authors
- Floras, J. S.
- Venue
- Hypertension
- Published
- 1992-01
- Volume
- 19
- Issue
- 1
- Pages
- 1-18
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2059632041
- Cited by
- 137
- References
- 8
- FWCI
- 8.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.